4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-063737
Chief Scientific Officer sold 30,426 shares at an average $32.96 ($1,002,751)
- Chief Scientific Officer acquired 30,426 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2024-05-20 | Option exercise 10b5-1 | +30,426 | $1.03 | $31,339 | 180,073 | D |
| Beskrovnaya Oxana Chief Scientific Officer | 2024-05-20 | Sale 10b5-1 | −17,134 | $32.49 | $556,684 | 162,939 | D |
| Beskrovnaya Oxana Chief Scientific Officer | 2024-05-20 | Sale 10b5-1 | −12,147 | $33.51 | $407,046 | 150,792 | D |
| Beskrovnaya Oxana Chief Scientific Officer | 2024-05-20 | Sale 10b5-1 | −1,145 | $34.08 | $39,022 | 149,647 | D |
| Derivatives | |||||||
| Beskrovnaya Oxana Chief Scientific Officer | 2024-05-20 | Option exercise · Stock option (right to buy) 10b5-1 | −30,426 | 0 | D | ||
| Open-market sales · 30,426 sh · avg $32.96 · $1,002,751 | |||||||
Loading xslF345X05/ownership.xml…